213 related articles for article (PubMed ID: 37341004)
1. Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis.
Chung DY; Kang DH; Jung HD; Lee JY; Kim DK; Ha JS; Jeon J; Cho KS
Investig Clin Urol; 2023 May; 64(3):242-254. PubMed ID: 37341004
[TBL] [Abstract][Full Text] [Related]
2. Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer - an in-depth quantitative evaluation and retrospective cohort analysis.
Cheng B; He H; Chen B; Zhou Q; Luo T; Li K; Du T; Huang H
Int J Surg; 2024 Jun; 110(6):3190-3202. PubMed ID: 38498388
[TBL] [Abstract][Full Text] [Related]
3. An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer.
Yanagisawa T; Rajwa P; Kawada T; Bekku K; Laukhtina E; Deimling MV; Majdoub M; Chlosta M; Karakiewicz PI; Heidenreich A; Kimura T; Shariat SF
Curr Oncol; 2023 Feb; 30(2):2194-2216. PubMed ID: 36826131
[TBL] [Abstract][Full Text] [Related]
4. The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer.
Ranasinghe W; Chapin BF; Kim IY; Sooriakumaran P; Lawrentschuk N
BJU Int; 2020 Jun; 125(6):792-800. PubMed ID: 32176456
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis.
Mao Y; Hu M; Yang G; Gao E; Xu W
World J Surg Oncol; 2022 Aug; 20(1):255. PubMed ID: 35945562
[TBL] [Abstract][Full Text] [Related]
6. Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer-Translational Research Results from the Prospective ProMPT trial.
Mandel PC; Huland H; Tiebel A; Haese A; Salomon G; Budäus L; Tilki D; Chun F; Heinzer H; Graefen M; Pantel K; Riethdorf S; Steuber T
Eur Urol Focus; 2021 Jan; 7(1):55-62. PubMed ID: 31178293
[TBL] [Abstract][Full Text] [Related]
7. Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging.
Robesti D; Gallina A; Montorsi F; Briganti A; Fossati N
Curr Opin Urol; 2024 Jul; 34(4):294-299. PubMed ID: 38587018
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.
Rajwa P; Robesti D; Chaloupka M; Zattoni F; Giesen A; Huebner NA; Krzywon A; Miszczyk M; Moll M; Stando R; Cisero E; Semko S; Checcucci E; Devos G; Apfelbeck M; Gatti C; Marra G; van den Bergh RCN; Goldner G; Rasul S; Ceci F; Dal Moro F; Porpiglia F; Gontero P; Bjartell A; Stief C; Heidenreich A; Joniau S; Briganti A; Shariat SF; Gandaglia G;
Eur Urol Oncol; 2023 Oct; ():. PubMed ID: 37845121
[TBL] [Abstract][Full Text] [Related]
9. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery in patients with oligometastatic prostate cancer. Systematic review of the scientific literature.
Ruiz Aragón J; Jiménez Varo E; Ruiz Aragón AI; Revelo Cadena I; Agüera Sánchez Á; Jiménez Romero ME
Actas Urol Esp (Engl Ed); 2023; 47(6):332-340. PubMed ID: 36319558
[TBL] [Abstract][Full Text] [Related]
12. Does surgery benefit patients with oligometastatic or metastatic prostate cancer? - A retrospective cohort study and meta-analysis.
Si S; Zheng B; Wang Z; Niu Z
Prostate; 2021 Aug; 81(11):736-744. PubMed ID: 34056739
[TBL] [Abstract][Full Text] [Related]
13. The cytoreductive radical prostatectomy in metastatic prostate cancer.
Vladimír Š; Zuzana S; Hana Š
Klin Onkol; 2022; 35(1):55-62. PubMed ID: 35236082
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review.
Becker JA; Berg KD; Røder MA; Brasso K; Iversen P
Scand J Urol; 2018 Feb; 52(1):1-7. PubMed ID: 28818014
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.
Heidenreich A; Fossati N; Pfister D; Suardi N; Montorsi F; Shariat S; Grubmüller B; Gandaglia G; Briganti A; Karnes RJ
Eur Urol Oncol; 2018 May; 1(1):46-53. PubMed ID: 31100228
[TBL] [Abstract][Full Text] [Related]
16. Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.
Heidenreich A; Pfister D
Curr Opin Urol; 2020 Jan; 30(1):90-97. PubMed ID: 31724996
[TBL] [Abstract][Full Text] [Related]
17. Current Controversy and Developments Regarding the Cytoreductive Prostatectomy for Oligometastatic Prostate Cancer.
Tian Y; Mao Y; Tang Z; Hu M
Technol Cancer Res Treat; 2023; 22():15330338231216011. PubMed ID: 38105493
[TBL] [Abstract][Full Text] [Related]
18. The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review.
Fossati N; Willemse PM; Van den Broeck T; van den Bergh RCN; Yuan CY; Briers E; Bellmunt J; Bolla M; Cornford P; De Santis M; MacPepple E; Henry AM; Mason MD; Matveev VB; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Lam TB; Mottet N; Joniau S
Eur Urol; 2017 Jul; 72(1):84-109. PubMed ID: 28126351
[TBL] [Abstract][Full Text] [Related]
19. The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis.
Tao R; Dai J; Bai Y; Yang J; Sun G; Zhang X; Zhao J; Zeng H; Shen P
Radiat Oncol; 2019 Nov; 14(1):197. PubMed ID: 31706339
[TBL] [Abstract][Full Text] [Related]
20. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes.
Preisser F; Chun FKH; Pompe RS; Heinze A; Salomon G; Graefen M; Huland H; Tilki D
Eur Urol; 2019 Jul; 76(1):106-114. PubMed ID: 30772034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
